- Home
- CLPT vs RGNX Comparison
CLPT vs RGNX Comparison
Compare CLPT & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLPT | RGNX |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 451.3M | 528.6M |
| IPO Year | 2009 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CLPT | RGNX |
|---|---|---|
| Price | $14.12 | $9.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $20.00 | ★ $28.75 |
| AVG Volume (30 Days) | 580.5K | ★ 2.5M |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.08 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $36,971,000.00 | $10,393,000.00 |
| Revenue This Year | $45.67 | $51.21 |
| Revenue Next Year | $19.51 | $19.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 17.78 | ★ 126.48 |
| 52 Week Low | $8.27 | $5.46 |
| 52 Week High | $30.10 | $16.19 |
Technical Indicators
Market Signals| Indicator | CLPT | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 38.38 | 41.84 |
| Support Level | $13.38 | $9.51 |
| Resistance Level | $15.09 | $10.16 |
| Average True Range (ATR) | 0.79 | 1.04 |
| MACD | -0.46 | -0.56 |
| Stochastic Oscillator | 7.03 | 17.69 |
Price Performance
Historical ComparisonAbout CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.